Trial intelligence / Profile preview

Monofer for Transfusion Reduction in Complex Valvular Heart Surgery

NCT02862665Completed

Sponsor
Yonsei University
Start
Aug 2016
Primary completion
May 2020
Modality
Inorganic Nanoparticles, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ferric derisomaltose in postoperative anemia (2 arms), sponsored by Yonsei University. Primary endpoint: Proportion of patients who need blood transfusion up to 10 days. Started Aug 2016; status: completed.

02

Drugs

ferric derisomaltose
03

Conditions

postoperative anemia

Beyond the preview

Go deeper on NCT02862665.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02862665.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call